IP Library › Granted Patent US 11,926,819
Granted Patent B2
US 11,926,819 · App. 16/886,398 · Granted Mar 12, 2024

Methods of adding polymers to ribonucleic acids

Inventors: Manuel Ares (Santa Cruz, CA); Logan Mulroney (Santa Cruz, CA); Jenny Vo (Santa Cruz, CA); Mark Akeson (Santa Cruz, CA)
Assignee: The Regents of the University of California
C12N15/102C12N9/1282C12Y207/07052C12Y207/07072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,926,819
App. No.
16/886,398
Granted
Mar 12, 2024
Kind
B2
Abstract

Provided are methods of adding a polymer of non-canonical nucleotides to the 3′ end of a ribonucleic acid (RNA). In certain embodiments, the methods comprise combining an RNA, a polynucleotide-3′ nucleotidyl transferase, and non-canonical nucleotides, in a reaction mixture under conditions in which the polynucleotide-3′ nucleotidyl transferase adds a polymer of the non-canonical nucleotides to the 3′ end of the RNA. Such methods may further include analyzing the RNA using a nanopore. According to some embodiments, the methods include identifying the polymer of non-canonical nucleotides added to the 3′ end of the RNA, and determining the junction between the 3′ end of the RNA and the polymer of non-canonical nucleotides to identify the 3′ end of the RNA. Kits that find use, e.g., in practicing the methods of the present disclosure are also provided.

Claims (15)

1. A method of adding a polymer of non-canonical nucleotides to the 3′ end of a ribonucleic acid (RNA), comprising combining:

an RNA;

a Schizosaccharomyces pombe cid1 ( S. pombe cid1) uridylyltransferase; and

non-canonical nucleotides, in a reaction mixture under conditions in which the S. pombe cid1 uridylyltransferase the non-canonical nucleotides to the 3′ end of the RNA, thereby adding a polymer of non-canonical nucleotides to the 3′ end of the RNA.

2. The method according to claim 1 , wherein the S. pombe cid1 uridylyltransferase comprises an N-terminal truncation, and wherein the amino acid sequence of the S. pombe cid1 uridylyltransferase is at least 80% identical to the corresponding portion of Schizosaccharomyces pombe cid1 ( S. pombe cid1) (SEQ ID NO:1).

3. The method according to claim 2 , wherein the S. pombe cid1 uridylyltransferase comprises an N-terminal truncation of from 20 to 40 amino acids.

4. The method according to claim 1 , wherein a homopolymer of non-canonical nucleotides is added to the 3′ end of the RNA.

5. The method according to claim 4 , wherein the homopolymer is a homopolymer of inosine, 5-methyluracil (ribothymidine), 4-thiouracil, 6-methyladenine, or 2′-O-methlyadenine.

6. The method according to claim 1 , wherein a heteropolymer of non-canonical nucleotides is added to the 3′ end of the RNA.

7. The method according to claim 6 , wherein the heteropolymer comprises two or more types of non-canonical nucleotides selected from the group consisting of: inosines, 5-methyluracil (ribothymidine), 4-thiouracil, 6-methyladenine, and 2′-O-methlyadenine.

8. The method according to claim 6 , wherein the heteropolymer comprises inosines.

9. The method according to claim 1 , wherein from 5 to 500 non-canonical nucleotides are added to the 3′ end of the RNA.

10. The method according to claim 1 , wherein from 5 to 100 non-canonical nucleotides are added to the 3′ end of the RNA.

11. The method according to claim 1 , wherein the RNA combined in the reaction mixture is a polyadenylated RNA.

12. The method according to claim 1 , wherein the RNA is eukaryotic mRNA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2022
From: ARES, MANUEL; MULRONEY, LOGAN; VO, JENNY; AKESON, MARK
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 059469/0680 →
Continuity (2)
Provisional Application 62853567 · May 28, 2019
Related Publication 20200377875A1 · Dec 3, 2020